Two people have died and one person was hospitalized after a possible overdose in Scott County. The incident happened around 6:45 p.m. on Thursday, May 2 at a home in ...
In a move that health experts say may reduce the number of fentanyl deaths, the FDA has approved over-the-counter sales of ...
By Chris Wack Amneal Pharmaceuticals shares were up 9% after the Food and Drug Administration approved an abbreviated new drug application ...
The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...
House approves $61 billion Ukraine aid package as lawmakers race to deliver fresh round of US support to war-torn ally WASHINGTON -- House approves $61 billion Ukraine aid package as lawmakers ...
3-5 The review of this application was conducted under the FDA's Project Orbis initiative, which provides a framework for concurrent submission and review of oncology medicines among international ...
(RTTNews) - Genentech, a member of the Roche Group (RHHBY), said that the U.S. Food and Drug Administration has approved Alecensa (alectinib) for adjuvant treatment following tumor resection for ...
OSAKA, Japan & CAMBRIDGE, Mass. - Takeda Pharmaceutical Company (NYSE:TAK) Limited (TSE:4502/NYSE:TAK) has received approval from the U.S. Food and Drug Administration (FDA) for the subcutaneous ...
Basel, 19 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumour ...
The FDA has approved Roche’s Alecensa for the treatment of early stage resected non-small cell lung cancer, or NSCLC, with ALK+ mutations. Roche said that the approval makes Alecensa the first ...
The Food and Drug Administration (FDA) has approved Alecensa (alectinib) for the treatment of patients with ALK-positive non-small cell lung cancer (NSCLC) that is 4 cm or larger and has been ...
Approval was supported by data from a randomized, intra-patient controlled trial, which included patients with confirmed invasive breast cancer, ductal carcinoma in situ, or both. The Food and ...